Kiniksa Pharmaceuticals International (KNSA) Receivables (2021 - 2026)
Kiniksa Pharmaceuticals International's (KNSA) quarterly Receivables came in at $23.5 million in Q2 2026, down 26.39% YoY from $31.9 million in Q2 2025, and up 1.15% on a QoQ basis from $23.2 million in Q1 2026.
Kiniksa Pharmaceuticals International (KNSA) Receivables (2021 - 2026) Analysis & Trends
Kiniksa Pharmaceuticals International (KNSA) has 6 years of Receivables data on file, last reported at $23.5 million in Q2 2026.
- Quarterly Receivables fell 26.39% year-over-year to $23.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $23.5 million (down 26.39% YoY) and the FY2025 annual result came in at $15.6 million, down 62.63% from the prior year.
- Receivables grew to $23.5 million in Q2 2026, from $23.2 million in the prior quarter.
- In the past five years, Receivables ranged from a high of $51.7 million in Q3 2025 to a low of $3.0 million in Q3 2023.
- A 5-year average of $23.0 million and a median of $22.2 million in 2023 frame the typical range for Receivables.
- Annual changes were most pronounced in 2023 — Receivables tumbled 74.78% — and 2024, when it jumped 718.41%.
- Tracing KNSA's Receivables over 5 years: stood at $20.3 million in 2022, then advanced by 4.68% to $21.3 million in 2023, then soared by 96.2% to $41.7 million in 2024, then sank by 62.63% to $15.6 million in 2025, then soared by 50.63% to $23.5 million in 2026.
- The last three Receivables figures came in at $23.5 million (Q2 2026), $23.2 million (Q1 2026), and $15.6 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 3.07 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 3.49 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 1.57 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 5.84 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 310.30 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 3.67 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 887.00 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1.15 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 1.08 Bn |
| 10 | Kiniksa Pharmaceuticals International | 6.05 Bn | 5.53 Bn | 220.03 Mn | 23.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23.49 Mn |
| Mar 31, 2026 | 23.22 Mn |
| Dec 31, 2025 | 15.59 Mn |
| Sep 30, 2025 | 51.74 Mn |
| Jun 30, 2025 | 31.91 Mn |
| Mar 31, 2025 | 40.07 Mn |
| Dec 31, 2024 | 41.72 Mn |
| Sep 30, 2024 | 24.89 Mn |
| Jun 30, 2024 | 20.45 Mn |
| Mar 31, 2024 | 16.00 Mn |
| Dec 31, 2023 | 21.27 Mn |
| Sep 30, 2023 | 3.04 Mn |
| Jun 30, 2023 | 24.65 Mn |
| Mar 31, 2023 | 7.42 Mn |
| Dec 31, 2022 | 20.32 Mn |
| Sep 30, 2022 | 11.16 Mn |
| Jun 30, 2022 | 7.81 Mn |
| Mar 31, 2022 | 29.44 Mn |
| Dec 31, 2021 | 3.99 Mn |
| Sep 30, 2021 | 3.22 Mn |